Tag: Rare

Rare baby names that became popular overnight

We’ve all heard of iconically popular names (like Peter, Jessica, etc.) becoming, well, even more popular overnight. And even rare celebrity baby names have been known to rise suddenly to the top of the charts after they debut. But how does one explain truly rare baby names that have suddenly started soaring in usage, with

Rare bacteria boosts immunotherapy in prostate cancer

A unique bacterial strain isolated from a patient with pelvic pain may represent a promising path to treating prostate cancer with immunotherapy, according to a Northwestern Medicine study published in Nature Communications. The study demonstrated how the bacterial strain travels directly to the prostate and induces low-level inflammation, boosting the effectiveness of immune checkpoint inhibitor

New tool predicts deadly form of rare cancer

Two patients with mycosis fungoides (MF) can appear to have identical diseases upon first diagnosis but can have radically different outcomes. MF in an unusual cancer of the T lymphocyte that begins in the skin rather than in the lymph nodes, with the first sign often being a rash. Most patients with MF, the most

Delayed coronary obstruction rare after TAVR

(HealthDay)—Delayed coronary obstruction (DCO) after transcatheter aortic valve replacement (TAVR) is a rare phenomenon but is associated with a high in-hospital mortality rate, according to a study published in the April 10 issue the Journal of the American College of Cardiology. Richard J. Jabbour, M.D., from Imperial College London, and colleagues used a large international

Could statins ease deadly heart condition in rare neuromuscular disease?

In preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich’s ataxia (FA), a widely used cholesterol-lowering drug increased a precursor of HDL (high-density lipoprotein), the “good cholesterol,” according to new research published in PLOS ONE from the Perelman School of Medicine at the University of Pennsylvania. Decreased HDL

New drug combo improves survival of women with rare uterine cancer

Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.